Brazil’s ANVISA Globalizes on Class I/II Medtech Regs, Hikes Fees
This article was originally published in Clinica
Executive Summary
New medical technology resolutions issued by Brazil’s healthcare products regulatory agency, ANVISA, are designed to help both the regulator and medtech manufacturers, in terms of simplified processes and speed to market.